down arrow

Cisen Pharmaceutical Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002VG4
CNY
18.18
2.39 (15.14%)

Dec 04

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Cisen Pharmaceutical Ltd.
Why is Cisen Pharmaceutical Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -0.86% and Operating profit at 0.52% over the last 5 years
2
The company has declared Negative results for the last 3 consecutive quarters
  • NET SALES(Q) At CNY 908.32 MM has Fallen at -19.97%
  • DEBTORS TURNOVER RATIO(HY) Lowest at 2.94%
  • OPERATING PROFIT(Q) Lowest at CNY 117.4 MM
3
With ROE of 7.41%, it has a very attractive valuation with a 1.49 Price to Book Value
  • Over the past year, while the stock has generated a return of 25.38%, its profits have fallen by -18.8%
  • At the current price, the company has a high dividend yield of 2.2
4
Market Beating Performance
  • The stock has generated a return of 25.38% in the last 1 year, much higher than market (China Shanghai Composite) returns of 14.77%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Cisen Pharmaceutical Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Cisen Pharmaceutical Ltd. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Cisen Pharmaceutical Ltd.
-100.0%
0.34
50.08%
China Shanghai Composite
14.77%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-0.86%
EBIT Growth (5y)
0.52%
EBIT to Interest (avg)
61.55
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
0.68
Tax Ratio
9.90%
Dividend Payout Ratio
39.15%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.05%
ROE (avg)
7.85%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
1.49
EV to EBIT
16.44
EV to EBITDA
11.76
EV to Capital Employed
1.89
EV to Sales
1.75
PEG Ratio
NA
Dividend Yield
2.20%
ROCE (Latest)
11.49%
ROE (Latest)
7.41%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

RAW MATERIAL COST(Y)

Fallen by -0.71% (YoY

-13What is not working for the Company
NET SALES(Q)

At CNY 908.32 MM has Fallen at -19.97%

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.94%

OPERATING PROFIT(Q)

Lowest at CNY 117.4 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 12.93 %

Here's what is working for Cisen Pharmaceutical Ltd.
Raw Material Cost
Fallen by -0.71% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Cisen Pharmaceutical Ltd.
Net Sales
At CNY 908.32 MM has Fallen at -19.97%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (CNY MM)

Net Sales
Lowest at CNY 908.32 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit
Lowest at CNY 117.4 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at 12.93 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Debtors Turnover Ratio
Lowest at 2.94%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."